European shares fall after three days of gains as Roche weighs

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)

March 30 (Reuters) - European shares fell on Wednesday, pulled lower by Swiss drugmaker Roche, with the STOXX 600 index retreating after three straight sessions of cautious gains that were driven by hopes of a breakthrough in Russia-Ukraine peace talks.

Roche ROG.S fell 1.3% after it said its drug to treat small cell lung cancer failed to meet its targets in a late-stage trial.

The drugmaker weighed heavily on the European healthcare sector .SXDP , which was down 0.6%, while also dragging down the pan-European index .STOXX by a similar margin.

The STOXX 600 closed at levels seen before the war on Tuesday after peace talks between Russia and Ukraine yielded the most tangible sign of progress toward negotiating an end to the war.

According to British Intelligence, some Russian units suffering heavy losses in Ukraine had been forced to return home and to neighbouring Belarus.

Commodities-exposed sectors, including miners .SXPP and energy .SXEP , were in positive territory in the first hour of trading, rising about 1% each as prices of oil and industrial metals rebounded.

Ericsson ERICb.ST shares fell 0.6% after investors publicly rebuked Chief Executive Borje Ekholm and the telecom equipment maker's board over a scandal involving potential payments to Islamic State.
Reporting by Shreyashi Sanyal in Bengaluru; Editing by Anil D'Silva

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。


本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

我們運用 cookies 提供您最佳之網頁使用經驗。更改您的cookie 設定跟詳情。